Kits Eyecare (TSE:KITS) Insider Joseph Thompson Sells 75,000 Shares of Stock

Kits Eyecare Ltd (TSE:KITSGet Free Report) insider Joseph Thompson sold 75,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of C$13.65, for a total value of C$1,023,750.00. Following the completion of the transaction, the insider directly owned 960,114 shares in the company, valued at C$13,105,556.10. The trade was a 7.25% decrease in their position.

Kits Eyecare Stock Up 10.0%

Kits Eyecare stock opened at C$14.67 on Friday. Kits Eyecare Ltd has a 12 month low of C$10.61 and a 12 month high of C$22.56. The company has a 50 day moving average price of C$13.56. The firm has a market capitalization of C$498.71 million, a P/E ratio of 146.70 and a beta of 0.11.

Kits Eyecare (TSE:KITSGet Free Report) last posted its earnings results on Wednesday, May 6th. The company reported C$0.06 EPS for the quarter. The firm had revenue of C$57.47 million during the quarter.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on KITS shares. Stifel Nicolaus reduced their price target on Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. ATB Cormark Capital Markets reduced their price target on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating on the stock in a research report on Thursday, May 7th. Desjardins reduced their price target on Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Canaccord Genuity Group reduced their price target on Kits Eyecare from C$23.00 to C$22.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of C$20.69.

View Our Latest Analysis on Kits Eyecare

About Kits Eyecare

(Get Free Report)

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.

Featured Articles

Receive News & Ratings for Kits Eyecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kits Eyecare and related companies with MarketBeat.com's FREE daily email newsletter.